Accessibility helpSkip to navigationSkip to contentSkip to footer

Cookies on FT Sites

We use cookies for a number of reasons, such as keeping FT Sites reliable and secure, personalising content and ads, providing social media features and to analyse how our Sites are used.

Accept & continue
Manage cookies
  • Sign In
  • Subscribe
Open side navigation menuOpen search bar
Financial Times
SubscribeSign InmyFT
  • Home
  • World
    Sections
    • World Home
    • Global Economy
    • UK
    • US
    • China
    • Africa
    • Asia Pacific
    • Emerging Markets
    • Europe
    • War in Ukraine
    • Americas
    • Middle East & North Africa
    • Australia & NZ
    Most Read
    • UK mortgage rates rise at fastest pace in a decade
    • Cern scientists restart hunt for answers to mysteries of universe
    • UK science minister in dispute with Treasury over post-Brexit funding
    • Eurozone inflation hits record 8.6% in June
    • ‘It’s hard to leave’: Moscow’s fresh wave of missile attacks rekindle Kyivans’ fear
  • US
    Sections
    • US Home
    • US Economy
    • US Companies
    • US Politics & Policy
    Most Read
    • When it comes to inflation, it’s not déjà vu all over again
    • US government bonds rally after factory data heighten recession fears
    • Chinese hackers kept up hiring drive despite FBI indictment
    • Google closes data loophole amid privacy fears over abortion ruling
    • Central banks look to China’s renminbi to diversify foreign currency reserves
  • Companies
    Sections
    • Companies Home
    • Energy
    • Financials
    • Health
    • Industrials
    • Media
    • Professional Services
    • Retail & Consumer
    • Tech Sector
    • Telecoms
    • Transport
    Most Read
    • Klarna valuation crashes to $6.5bn from $46bn
    • Ryanair chief warns fares will rise for 5 years because flying is ‘too cheap’
    • Boots left in limbo as bids fail to emerge
    • Vatican suffers £100mn-plus loss on Knightsbridge office sale
    • Covid could not sink cruise lines — but they now face an iceberg of debt
  • Tech
  • Markets
    Sections
    • Markets Home
    • Alphaville
    • Markets Data
    • Capital Markets
    • Commodities
    • Currencies
    • Equities
    • Fund Management
    • Trading
    • Moral Money
    • ETF Hub
    • Cryptocurrencies
    Most Read
    • Klarna valuation crashes to $6.5bn from $46bn
    • US government bonds rally after factory data heighten recession fears
    • A soft landing is becoming a distant dream
    • The looming risks in private equity returns
    • Live news updates from July 1: Crypto in focus as FTX buys BlockFi and Voyager Digital halts trading, Eurozone inflation hits record
  • Climate
  • Opinion
    Sections
    • Opinion Home
    • Columnists
    • The FT View
    • The Big Read
    • Lex
    • Obituaries
    • Letters
    Most Read
    • The end of the frictionless life
    • When it comes to inflation, it’s not déjà vu all over again
    • A soft landing is becoming a distant dream
    • Mukesh Ambani: India’s top businessman starts succession planning
    • Time to change my subscription model
  • Work & Careers
    Sections
    • Work & Careers Home
    • Business School Rankings
    • Business Education
    • Entrepreneurship
    • Recruitment
    • Business Books
    • Business Travel
    Most Read
    • How can I move from being a specialist police detective to financial services?
    • What’s a good (and bad) way to leave your job?
    • If you want to be more likeable, try showing more stress
    • ‘Exactly how much virtue do you really want to signal?’
    • JSR’s Eric Johnson: ‘I encourage people to tell me exactly how they think’
  • Life & Arts
    Sections
    • Life & Arts Home
    • Arts
    • Books
    • Food & Drink
    • FT Magazine
    • House & Home
    • Style
    • Travel
    • FT Globetrotter
    Most Read
    • Serhii Plokhy: Putin’s imperialist narrative ‘is being crushed’
    • Life on the idyllic Swedish island where WW3 could start
    • The end of the frictionless life
    • Have we had enough of the nanny employer?
    • Swimsuits to make a splash in 
  • HTSI
MenuSearch
  • Home
  • World
  • US
  • Companies
  • Tech
  • Markets
  • Climate
  • Opinion
  • Work & Careers
  • Life & Arts
  • HTSI
Financial Times
SubscribeSign In

Your guide to a disrupted world

Start a 4-week trial

Antibiotic resistance

Add to myFT Digest

Add this topic to your myFT Digest for news straight to your inbox

  • Thursday, 26 May, 2022
    Special ReportFT Health: Future of Antibiotics
    Vaccines hold potential to curb antibiotic resistance

    Prevention is better than cure — but is too costly for some countries where drug-resistant bacteria are rampant

  • Thursday, 26 May, 2022
    Special ReportFT Health: Future of Antibiotics
    Diagnostic tests a crucial tool in fight against antibiotic resistance

    Identifying conditions can prevent inappropriate drug use, but there are barriers to progress in poorer regions

  • Monday, 18 April, 2022
    Lex
    Antibiotics: new incentives needed to fight superbugs Premium content

    Global co-operation is desperately needed to overcome threat from drug-resistant infections

  • Wednesday, 13 April, 2022
    Ramanan Laxminarayan
    Greater access to antibiotics is essential for curbing drug resistance

    Broader funding, registration and stewardship is pivotal to making the antibiotic market more sustainable

  • Wednesday, 13 April, 2022
    Special ReportFT Health: Future of Antibiotics
    Drug pollution in rivers raises risks of antibiotic resistance

    Study finds lower middle income countries in South Asia and Latin America have highest levels of pollutants

  • Tuesday, 12 April, 2022
    How will UK’s fixed-fee scheme for antibiotics help tackle the growing health crisis?

    Move could boost global development of drugs to ease antimicrobial resistance

  • Monday, 11 April, 2022
    UK launches world-first ‘subscription’ model for antibiotic supply

    Fixed fee aims to incentivise pharma groups to develop new drugs and curb overprescription

  • Monday, 7 March, 2022
    Special ReportFT Health: Future of Antibiotics
    Antibiotic resistance in Africa: ‘a pandemic that is already here’

    Drug-resistant pathogens and poor hygiene mean simple procedures can deteriorate into lengthy and costly infections

  • Monday, 7 March, 2022
    Special ReportFT Health: Future of Antibiotics
    How pharma economics hold back antibiotic development

    New drugs are needed as resistance grows but plans to improve incentives are too modest, executives say

  • Friday, 28 January, 2022
    Sally Davies
    It’s time to confront the pandemic of antibiotic resistance

    To save lives and economies, we must make progress by drawing on lessons from Covid-19

  • Thursday, 20 January, 2022
    Special ReportFT Health: Future of Antibiotics
    Antibiotic resistance kills over 1m people a year, says study

    Research underscores the dangers of bacteria developing the ability to resist drugs

  • Wednesday, 24 November, 2021
    Special ReportFT Health: Future of Antibiotics
    Antibiotic accountability: how countries and companies perform

    FT dashboard tracks responses to the growing threat of antimicrobial resistance

  • Friday, 19 November, 2021
    Special ReportFT Health: Future of Antibiotics
    Pressure grows for funding to tackle ‘silent pandemic’ of antimicrobial resistance

    Political will is needed to address absence of sufficient financial incentives for new drugs

  • Thursday, 18 November, 2021
    Special ReportFT Health: Future of Antibiotics
    Limited access to antibiotics is driving resistance, warns watchdog

    Failure to ensure they reach world’s poorest increases health risks, says pharma body

  • Monday, 27 September, 2021
    Special Report
    FT Health: Communicable Diseases

    The pandemic highlighted weaknesses in global health systems but has spurred a powerful response. Plus: how climate change risks backsliding on gains against malaria; long Covid perplexes researchers; new HIV treatments in the pipeline; why the fight against antimicrobial resistance is making slow progress

  • Monday, 27 September, 2021
    Special ReportFT Health: Communicable Diseases
    Governments fall behind in race to stem antimicrobial resistance

    Without decisive action, there could be 10m deaths a year due to AMR by 2050 — and a cumulative cost to the global economy of $100tn

  • Sunday, 19 September, 2021
    Rapid test to distinguish bacterial and viral infections wins US approval

    Israeli start-up MeMed aims to cut unnecessary prescribing of antibiotics with 15-minute procedure

  • Wednesday, 2 June, 2021
    Alarm raised over use of antibiotics for UK Covid patients

    Medics turning unnecessarily to antibacterials during first wave triggers concern over accelerated resistance

  • Thursday, 15 April, 2021
    WHO sounds alarm on drug-resistant bacteria

    Global health body warns none of antibiotics currently being developed are enough to tackle superbugs

  • Monday, 5 April, 2021
    Lex
    Antibiotics: Netflix-style subscriptions target superbugs Premium content

    The current pandemic has shown the value of planning ahead of crises

  • Friday, 5 March, 2021
    Special ReportFT Health: Future of Antibiotics
    Antibiotic resistance: how to tackle a public health crisis

    Recommendations from two FT roundtables with pharma, government, and NGO experts

  • Wednesday, 10 February, 2021
    Special ReportFT Health: Future of Antibiotics
    Push and pull: funding drugs to be used only sparingly

    New models are emerging to allow pharma companies to turn a profit regardless of how much new antibiotics are used

  • Friday, 22 January, 2021
    Marc Mendelson
    The silent pandemic of antibiotic resistance

    A South African doctor’s prescription to stop poorer countries losing access to many of modern medicine’s advances

  • Thursday, 21 January, 2021
    Special ReportFT Health: Future of Antibiotics
    Overuse of antibiotics for meat production drives resistance in humans

    Household names like McDonald’s start to modify practices to aid farm animals’ health, growth and digestion

  • Tuesday, 19 January, 2021
    Ineos gives Oxford £100m to set up antibiotic research institute

    Chemicals company makes largest donation for science in university’s history

Previous page You are on page 1 Next page

Useful links

Support

View Site TipsHelp CentreContact UsAbout UsAccessibilitymyFT TourCareers

Legal & Privacy

Terms & ConditionsPrivacy PolicyCookiesCopyrightSlavery Statement & Policies

Services

Share News Tips SecurelyIndividual SubscriptionsGroup SubscriptionsRepublishingExecutive Job SearchAdvertise with the FTFollow the FT on TwitterFT TransactSecondary Schools

Tools

PortfolioToday's Newspaper (ePaper)Alerts HubBusiness School RankingsEnterprise ToolsNews feedNewslettersCurrency Converter

Community & Events

FT CommunityFT LiveFT ForumsFT Board DirectorBoard Director Programme

More from the FT Group

Markets data delayed by at least 15 minutes. © THE FINANCIAL TIMES LTD 2022. FT and ‘Financial Times’ are trademarks of The Financial Times Ltd.
The Financial Times and its journalism are subject to a self-regulation regime under the FT Editorial Code of Practice.
Financial Times

International Edition

Subscribe for full access
  • Switch to UK Edition
  • Top sections
  • Home
  • World
    • Global Economy
    • UK
    • US
    • China
    • Africa
    • Asia Pacific
    • Emerging Markets
    • Europe
    • War in Ukraine
    • Americas
    • Middle East & North Africa
    • Australia & NZ
  • US
    • US Economy
    • US Companies
    • US Politics & Policy
  • Companies
    • Energy
    • Financials
    • Health
    • Industrials
    • Media
    • Professional Services
    • Retail & Consumer
    • Tech Sector
    • Telecoms
    • Transport
  • Tech
  • Markets
    • Alphaville
    • Markets Data
    • Capital Markets
    • Commodities
    • Currencies
    • Equities
    • Fund Management
    • Trading
    • Moral Money
    • ETF Hub
    • Cryptocurrencies
  • Climate
  • Opinion
    • Columnists
    • The FT View
    • The Big Read
    • Lex
    • Obituaries
    • Letters
  • Work & Careers
    • Business School Rankings
    • Business Education
    • Entrepreneurship
    • Recruitment
    • Business Books
    • Business Travel
  • Life & Arts
    • Arts
    • Books
    • Food & Drink
    • FT Magazine
    • House & Home
    • Style
    • Travel
    • FT Globetrotter
  • Personal Finance
    • Property & Mortgages
    • Investments
    • Pensions
    • Tax
    • Banking & Savings
    • Advice & Comment
    • Next Act
  • HTSI
  • Special Reports
  • FT recommends
  • Lex
  • Alphaville
  • Lunch with the FT
  • FT Globetrotter
  • #techAsia
  • Moral Money
  • FTfm
  • Newsletters
  • Video
  • Podcasts
  • News feed
  • FT Community
    • FT Live
    • FT Forums
    • Board Director Programme
  • myFT
  • Portfolio
  • Today's Newspaper (ePaper)
  • Crossword
  • Our Apps
  • Help Centre
  • Subscribe
  • Sign In